Completed OBSERVATIONAL NCT04412161

Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP

Retrospective Cohort Study-Analysis of LT Patients With HCC (Maximum Tumor Diameter > 6 cm).

Sponsor: Inonu University

Conditions Hepatocellular Carcinoma Liver Transplant Disorder

Updated 4 times since 2020 Last updated: May 29, 2020 Started: Apr 19, 2006 Primary completion: Jan 1, 2019 Completion: Dec 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Hepatocellular Carcinoma and Liver Transplant Disorder, this trial is completed. The trial is conducted by Inonu University and has accumulated 4 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jul 2020 — Jan 2021 [monthly]

Completed

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Inonu University

Data source: Inonu University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.